FDA warns against unapproved versions of Botox

12/28/2012 | Medical News Today

The FDA warned against the use of unapproved versions of wrinkle fighter Botox as well as other drugs from Canada Drugs and its subsidiaries. The products could be unsafe, ineffective, counterfeit and contaminated, the FDA said. The FDA asked the practices to stop using the treatments in patients.

View Full Article in:

Medical News Today